Results 171 to 180 of about 3,564,494 (317)

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Community research to elevate women’s health

open access: yesThe Lancet Primary Care
The Lancet Primary Care
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Patient violence at the frontline of care

open access: yesThe Lancet Primary Care
The Lancet Primary Care
doaj   +1 more source

Correction to: Characteristics of a COVID-19 confirmed case series in primary care (COVID-19-PC project): a cross-sectional study

open access: yesBMC Family Practice, 2021
Eloisa Rogero-Blanco   +6 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Primary Care Groups and Primary Care Trusts

open access: yesJournal of the Royal College of Physicians of London, 1999
openaire   +2 more sources

Thank you to The Lancet Primary Care statistical and peer reviewers in 2025

open access: yesThe Lancet Primary Care
The Lancet Primary Care Editors
doaj   +1 more source

Home - About - Disclaimer - Privacy